These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 23072496

  • 1. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA, Shojaee A, Maa JF, Neutel JM.
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 3. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
    Weir MR, Shojaee A, Maa JF.
    Postgrad Med; 2013 Mar; 125(2):124-34. PubMed ID: 23816778
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA.
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD, Shojaee A, Maa JF, Weir MR.
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
    Germino FW, Neutel JM, Dubiel R, Maa JF, Chavanu KJ.
    Am J Cardiovasc Drugs; 2012 Oct 01; 12(5):325-33. PubMed ID: 22920048
    [Abstract] [Full Text] [Related]

  • 10. Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
    Lewin AJ, Izzo JL, Melino M, Lee J, Fernandez V, Heyrman R.
    Drugs Aging; 2013 Jul 01; 30(7):549-60. PubMed ID: 23549909
    [Abstract] [Full Text] [Related]

  • 11. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
    Weir MR, Hsueh WA, Nesbitt SD, Littlejohn TJ, Graff A, Shojaee A, Waverczak WF, Qian C, Jones CJ, Neutel JM.
    J Clin Hypertens (Greenwich); 2011 Jun 01; 13(6):404-12. PubMed ID: 21649839
    [Abstract] [Full Text] [Related]

  • 12. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
    Chrysant SG, Littlejohn T, Izzo JL, Kereiakes DJ, Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.
    Am J Cardiovasc Drugs; 2012 Aug 01; 12(4):233-43. PubMed ID: 22799613
    [Abstract] [Full Text] [Related]

  • 13. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
    Kereiakes DJ, Chrysant SG, Izzo JL, Littlejohn T, Melino M, Lee J, Fernandez V, Heyrman R.
    Cardiovasc Diabetol; 2012 Oct 30; 11():134. PubMed ID: 23110471
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.
    Clin Drug Investig; 2010 Oct 30; 30(9):581-97. PubMed ID: 20593911
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
    Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, Maa JF.
    Ther Adv Cardiovasc Dis; 2010 Aug 30; 4(4):209-21. PubMed ID: 20519261
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS, Kim CJ, Oh BH, Hong TJ, Park CG, Kim BS, Chung WB, Investigators.
    Am J Cardiovasc Drugs; 2016 Apr 30; 16(2):129-38. PubMed ID: 26691333
    [Abstract] [Full Text] [Related]

  • 17. Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertension.
    Punzi HA, Lewin A, Li W, Chavanu KJ.
    Adv Ther; 2012 Jun 30; 29(6):524-37. PubMed ID: 22763801
    [Abstract] [Full Text] [Related]

  • 18. An olmesartan medoxomil-based treatment algorithm is effective in achieving 24-hour BP control in patients with type 2 diabetes mellitus, regardless of age, race, sex, or severity of hypertension: subgroup analysis of the BENIFICIARY study.
    Neutel JM, Kereiakes DJ, BENIFICIARY Investigators.
    Am J Cardiovasc Drugs; 2010 Jun 30; 10(5):289-303. PubMed ID: 20712386
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
    Chrysant SG, Weber MA, Wang AC, Hinman DJ.
    Am J Hypertens; 2004 Mar 30; 17(3):252-9. PubMed ID: 15001200
    [Abstract] [Full Text] [Related]

  • 20. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
    Ram CV.
    Curr Med Res Opin; 2009 Jan 30; 25(1):177-85. PubMed ID: 19210150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.